← Back to Patent Explorer
US4585652A Expired / Lapsed US ⏱️ 0.0 years remaining

Electrochemical controlled release drug delivery system

Assignee: University of Minnesota System
•
Filing: 1984-11-19
•
Granted: 1986-04-29
•
Expires: 2004-11-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is disclosed for the controlled delivery of an ionic bioactive chemical into a physiological medium comprising ionically binding the chemical to redox sites on a charged polymer and releasing the bound chemical into the medium by neutralizing the charge on the polymer.

Inventors

  • 👤 Larry L. Miller
  • 👤 Ronald L. Blankespoor
  • 👤 Baruch Zinger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 02:52
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0002; A61K9/0009; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/559; Y; Y10; Y10S; Y10S424/00; Y10S424/07

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 59 words
A method for the controlled delivery of an ionic bioactive chemical into a physiological medium comprising: (a) ionically binding said chemical to a polymeric body comprising oppositely-charged redox sites; (b) contacting said polymeric body with said physiological medium; and (c) releasing said bound chemical into said medium as an ionic species by neutralizing the charge on the polymeric body.
Claim 2
Independent Claim 59 words
A method for the controlled delivery of an ionic bioactive chemical into a physiological medium comprising: (a) ionically binding said chemical to a polymeric body comprising oppositely-charged redox sites; (b) contacting said polymeric body with said physiological medium; and (c) releasing said bound chemical into said medium as an ionic species by neutralizing the charge on the polymeric body.
Claim 3
Dependent Claim 11 words
The method of claim 1 wherein said polymeric body is conductive.
Claim 4
Dependent Claim 36 words
The method of claim 2 wherein the charged polymeric body comprises cationic sites and is employed to bind anionic chemicals which are released by employing a cathodic current to neutralize the charge on the polymeric body.
Claim 5
Dependent Claim 16 words
The method of claim 3 wherein the charged polymeric body comprises oxidized polypyrrole or oxidized poly(beta-methoxythiophene).
Claim 6
Dependent Claim 36 words
The method of claim 2 wherein the charged polymeric body comprises anionic sites and is employed to bind cationic chemicals which are released by employing an anodic current to neutralize the charge on the polymeric body.
Claim 7
Dependent Claim 19 words
The method of claim 5 wherein the charged polymeric body comprises a reduced polyacetylene or a reduced, modified polyquinone.
Claim 8
Dependent Claim 31 words
The method of claim 1 wherein an electrode comprising said polymeric body is employed to bind said chemical by charging said electrode in contact with a solution of said ionic chemical.
Claim 9
Dependent Claim 28 words
The method of claim 7 wherein the ionic chemical is intermittently released by neutralizing the charge on the polymeric body with a plurality of quantified pulses of current.
Claim 10
Dependent Claim 13 words
The method of claim 8 wherein said bound chemicals are released in vivo.
Claim 11
Dependent Claim 21 words
The method of claim 9 wherein said electrode is implanted in a patient's body cavity or attached to the patient's skin.
Claim 12
Dependent Claim 32 words
The method of claim 1 wherein said ionic bioactive chemical is the anion of a pharmaceutically-acceptable salt selected from the group consisting of phosphate, sulfate, bisulfite, carboxylate and acidic N--H group salts.
Claim 13
Dependent Claim 15 words
The method of claim 1 wherein said ionic bioactive chemical comprises a quaternary ammonium cation.
Claim 14
Dependent Claim 30 words
The method of claim 12 wherein said ionic bioactive chemical is the cation of a pharmaceutically-acceptable salt selected from the group consisting of thiazinium, pyridinium, pyrrolidinium, thiazolium and piperidinium salts.
Claim 15
Independent Claim 62 words
A system for the controlled release of a bioactive ionic chemical into a physiological medium comprising: (a) a working electrode comprising a charged conductive polymer; (b) a bioactive ionic chemical ionically bound to said electrode; and (c) means comprising a power supply of reversible polarity which is capable of charging or discharging said polymer by delivering an anodic or cathodic current thereto.
Claim 16
Independent Claim 62 words
A system for the controlled release of a bioactive ionic chemical into a physiological medium comprising: (a) a working electrode comprising a charged conductive polymer; (b) a bioactive ionic chemical ionically bound to said electrode; and (c) means comprising a power supply of reversible polarity which is capable of charging or discharging said polymer by delivering an anodic or cathodic current thereto.
Claim 17
Dependent Claim 20 words
The system of claim 14 wherein said electrode comprises a coating of said conductive polymer on an inert, conductive substrate.
Claim 18
Dependent Claim 14 words
The system of claim 14 wherein the electrode consists essentially of said conductive polymer.
Claim 19
Dependent Claim 14 words
The system of claim 14 wherein said polymer comprises a continuous, conjugated pi-electron network.
Claim 20
Dependent Claim 26 words
The system of claim 14 further comprising a variable resistor between said current supply means and said electrode effective to control the magnitude of the current.
Claim 21
Dependent Claim 38 words
The system of claim 14 wherein said current supply means comprises an electrode having sufficient electrochemical potential with respect to the working electrode to discharge the charged working electrode when both electrodes are contacted with a physiological medium.

References Cited (Backward Citations)

US3991755A Cited
US4140121A Cited
US4400250A Cited
US4506680A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-04-28 1989-10-28 1990-04-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-04-28 1993-10-28 1994-04-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-04-28 1997-10-28 1998-04-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag